SUCRALFATE ORAL SUSPENSION

SUCRALFATE · Glenmark Pharmaceuticals Inc., USA

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SUCRALFATE ORAL SUSPENSION, covering 2022-03-15 to 2026-01-05. Get the full timeline:

Most recent: FDA Approved: SUCRALFATE ORAL SUSPENSION — Original Application (Glenmark Pharmaceuticals Inc., USA)